Methyl 3-amino-6-bromopyrazine-2-carboxylate

Catalog No. :
ACOERD563
CAS No. :
6966-01-4
Molecular Formula :
C6H6BrN3O2
Molecular Weight :
232.04

IUPAC Name:methyl 3-amino-6-bromopyrazine-2-carboxylate

Methyl 3-amino-6-bromopyrazine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$131.00Login to see priceIn stockInquiry
500g97%$654.00Login to see priceIn stockInquiry
1000g97%$1117.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-amino-6-bromopyrazine-2-carboxylate
IUPAC Namemethyl 3-amino-6-bromopyrazine-2-carboxylate
MDL No.MFCD00834964
Molecular FormulaC6H6BrN3O2
Molecular Weight232.04
SMILESC1=C(Br)N=C(C(=N1)N)C(=O)OC
InChI KeyCNXSIRHOIFRMOB-UHFFFAOYSA-N
Synonym2-amino-3-methoxycarbonyl-5-bromopyrazine | Methyl 3-Amino-6-Bromopyrazine-2-Carboxylic Ester | AM20070383 | AS-18368 | EN300-370712 | EN300-199676 | Pyrazinecarboxylic acid, 3-amino-6-bromo-, methyl ester | 2-AMINO-5-BROMOPYRAZINE-3-CARBOXYLIC ACID METHY
CAS No.6966-01-4
PubChem CID227251

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H317
Precautionary Statement(s)
P261-P280

Synthetic Route by SureRoute

1. ACOERD563 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACZWLX480 route compound structure diagram
    ACZWLX480486424-37-7 In Stock
  4. Then
  5. ACOERD563 route product structure diagram
    ACOERD5636966-01-4 In Stock
Inquiry

2. ACOERD563 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBYRE798 route compound structure diagram
    ACBYRE79816298-03-6 In Stock
  4. Then
  5. ACOERD563 route product structure diagram
    ACOERD5636966-01-4 In Stock
Inquiry

Comments (0)